| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/22/1999 | WO1999025814B1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
| 07/22/1999 | WO1999024606A3 Specific and sensitive nucleic acid detection method |
| 07/22/1999 | WO1999024587A3 Human phospholipase a2 protein and dna encoding it |
| 07/22/1999 | WO1999024052A3 Use of protein h as cytostatic agent |
| 07/22/1999 | WO1999023250A3 Specific and sensitive method for detecting nucleic acids |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | WO1999019358B1 Antibody against baculoviruses |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | WO1999005291A3 Aggrecan degrading metallo proteases |
| 07/22/1999 | WO1998059040A3 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | WO1998008388A8 Pesticidal agents |
| 07/22/1999 | WO1997044469A8 Multiple epitope fusion protein |
| 07/22/1999 | DE19801780A1 Transgenic non-human mammal containing p53 knock-in gene, useful as model for carcinogenesis |
| 07/22/1999 | DE19801730A1 Analyzing cell contents, especially nucleic acids, useful for medical diagnostics |
| 07/22/1999 | DE19801120A1 New orotidine-5'-phosphate decarboxylase gene useful as selectable marker for microbial transformation |
| 07/22/1999 | DE19753681A1 Erythropoietin composition has a highly specific activity |
| 07/22/1999 | DE19718640A1 Protein derived from Anemonia useful in gene technology and molecular biology |
| 07/22/1999 | CA2319147A1 Yeast cell surface of proteins having enhanced properties |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318663A1 Methods and compositions for gene delivery |
| 07/22/1999 | CA2318662A1 Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
| 07/22/1999 | CA2318660A1 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | CA2318577A1 Multiplex vgid |
| 07/22/1999 | CA2318575A1 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | CA2318526A1 Process for the production of alanine by recombinant microorganisms |
| 07/22/1999 | CA2318439A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318377A1 Enzymatic conversion of gdp-mannose to gdp-fucose |
| 07/22/1999 | CA2318371A1 Method for the detection of nucleic acid sequences |
| 07/22/1999 | CA2318365A1 Polyketides and their synthesis |
| 07/22/1999 | CA2318363A1 Fatty acid transport proteins |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318242A1 Depositing fluid specimens on substrates, resulting ordered arrays, techniques for analysis of deposited arrays |
| 07/22/1999 | CA2318117A1 Efficient nuclear transfer using primordial germ cells |
| 07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | CA2317934A1 Novel promoter elements for persistent gene expression |
| 07/22/1999 | CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | CA2317838A1 Testis-specific human svph1-8 proteinase |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317810A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | CA2317677A1 Nucleobase oligomers |
| 07/22/1999 | CA2317449A1 Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2317094A1 Human protease molecules |
| 07/22/1999 | CA2317026A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/21/1999 | EP0930370A1 Labeled primer for use in detection of target nucleic acids |
| 07/21/1999 | EP0930367A2 Uni- or multicellular microorganisms for the production of riboflavin |
| 07/21/1999 | EP0930366A2 Binding domains in delta proteins |
| 07/21/1999 | EP0930365A2 Binding domains in serrate protein |
| 07/21/1999 | EP0930364A1 TWIK-1 related two domains potassium channel |
| 07/21/1999 | EP0930363A2 Immobilization of cohesive or adhesive cells and use thereof |
| 07/21/1999 | EP0930362A2 Method of synchronizing epithelial cells into Go phase |
| 07/21/1999 | EP0930009A1 Quiescent cell population for nuclear transfer |
| 07/21/1999 | EP0929693A2 Multiplex polynucleotide capture methods and compositions |
| 07/21/1999 | EP0929691A2 Methods and compositions for identifying receptor effectors |
| 07/21/1999 | EP0929689A2 Artifical chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929687A1 Mammary gland-specific promoters |
| 07/21/1999 | EP0929686A1 Early seed 5' regulatory sequence |
| 07/21/1999 | EP0929685A2 Transgenic plants with enhanced sulfur amino acid content |
| 07/21/1999 | EP0929684A2 Phospholipase d and dna sequences |
| 07/21/1999 | EP0929683A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 07/21/1999 | EP0929682A2 Materials and methods for the modification of plant lignin content |
| 07/21/1999 | EP0929681A1 Rifamycin biosynthesis gene cluster |
| 07/21/1999 | EP0929680A1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929678A2 Protein and peptide vaccines for inducing mucosal immunity |
| 07/21/1999 | EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 07/21/1999 | EP0929676A1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 07/21/1999 | EP0929675A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/21/1999 | EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929669A1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis |
| 07/21/1999 | EP0929668A1 Modulators of brca1 activity |
| 07/21/1999 | EP0929667A1 Hypertension markers |
| 07/21/1999 | EP0929666A1 Method for stably cloning large repeating dna sequences |
| 07/21/1999 | EP0929665A1 Cell-based drug screens for regulators of gene expression |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929663A1 Method of increasing growth and yield in plants |
| 07/21/1999 | EP0929579A1 Monoclonal antibodies against a human act and serine protease complex |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929577A1 Stabilized proteinaceous protease inhibitors and variants thereof |
| 07/21/1999 | EP0929576A1 Glp-2 derivatives |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929564A1 High level expression of proteins |
| 07/21/1999 | EP0929316A1 Novel product and process for t lymphocyte veto |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0929211A1 THE PROMOTER (FLt) FOR THE FULL-LENGTH TRANSCRIPT OF PEANUT CHLOROTIC STREAK CAULIMOVIRUS (PC1SV) |
| 07/21/1999 | EP0750663A4 Apparatus and method for efficient incorporation of molecules into cells |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |
| 07/21/1999 | EP0629239B1 Insecticidal toxins from the parasitic wasp bracon hebetor |
| 07/21/1999 | EP0594576B1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 07/21/1999 | EP0463064B1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit |